Celltrion merger
Scope
Date
~
-
Asset management
Mirae Asset aspires to No. 5 in Indian securities market with Sharekhan
South Korea’s leading asset manager Mirae Asset Financial Group will strive to grab the fifth-largest share of the Indian securities market th...
Nov 27, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Nov 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to acquire additional $72 mn in treasury shares
South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...
Nov 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires Swiss pharmaceutical distributor iQone
South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...
Nov 15, 2024 (Gmt+09:00)
-
Korean stock market
MSCI Korea Index adds Hyundai Rotem
MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...
Nov 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
Nov 05, 2024 (Gmt+09:00)
-
Corporate restructuring
SK Innovation-SK E&S merger creates Asia’s No. 1 energy supplier
SK Group on Friday launched the merged entity between SK Innovation Co. and liquefied natural gas supplier SK E&S Co., a key step in the energy-...
Nov 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra gets 90% distribution channel in US
South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...
Oct 30, 2024 (Gmt+09:00)
-
Corporate restructuring
Doosan to resume Bobcat, Robotics merger with new ratio
South Korea’s plant and machinery powerhouse Doosan Group will resume the merger of Doosan Bobcat Inc. and Doosan Robotics Inc. using a new me...
Oct 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
Oct 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Oct 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion establishes subsidiary in Vietnam
Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....
Sep 30, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion earmarks billions of dollars to build CDMO plant: chairman
Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...
Sep 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion chairman announces venture into CDMO market
South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...
Sep 09, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Doosan Bobcat scraps merger with Doosan Robotics
Doosan Group on Thursday scrapped a merger between heavy machinery maker Doosan Bobcat Inc. and collaborative robot manufacturer Doosan Robotics Inc...
Aug 29, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Innovation-SK E&S merger gains shareholders’ nod
SK Innovation Co., South Korea’s largest energy company, has won majority support from its shareholders for a merger with its liquefied natura...
Aug 27, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
S.Korea's Xingxing to merge Kickgoing
Pump Co., the operator of South Korea's personal mobility (PM) sharing service Xingxing, said on Monday that it will merge with Wololo, the company ...
Aug 27, 2024 (Gmt+09:00)
-
Pension funds
NPS to veto SK Innovation’s merger with LNG affiliate
South Korea’s National Pension Service (NPS), manager of the world’s third-largest public pension fund, said on Thursday it is set to ve...
Aug 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion scraps merger with Celltrion Pharm
South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...
Aug 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Costco sells Celltrion's Yuflyma Low WAC in US
South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...
Aug 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...
Aug 12, 2024 (Gmt+09:00)
-
Korean stock market
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Aug 11, 2024 (Gmt+09:00)
-
Food & Beverage
Lotte Wellfood eyes merger with trading arm; firms indecisives
South Korea’s Lotte Corp. is considering a merger of its confectionery unit Lotte Wellfood Co. and agricultural product trading arm Lotte Inte...
Aug 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra joins US insurance-covered drug lists
South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...
Aug 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Jul 31, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Doosan Robotics, Bobcat ordered to clarify merger deal
South Korean regulators have ordered Doosan Robotics Inc. to amend the securities prospectus it submitted last week for its merger with Doosan Bobca...
Jul 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s new plant in Songdo poised for commercial production
South Korea’s largest biosimilar maker Celltrion Inc. said on Tuesday that its third plant in Sondgo, west of Seoul, is undergoing process val...
Jul 23, 2024 (Gmt+09:00)
-
Corporate restructuring
Doosan Robotics, Bobcat merger prompts call for law revision
Doosan Group’s announcement of a merger between Doosan Robotics Inc. and Doosan Bobcat Inc. has met with strong criticism from investors and p...
Jul 22, 2024 (Gmt+09:00)
-
Corporate restructuring
SK Innovation to be Asia’s top energy company through merger
SK Innovation Co., South Korea’s largest energy company, is set to become the industry leader in Asia through a merger with an affiliate while...
Jul 17, 2024 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet